Can-Fite BioPharma Ltd. (CANF)

Can-Fite BioPharma Income Statement

Financials in millions ILS. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	0.74	0.74	0.81	0.85	0.76	2.03
Revenue Growth (YoY)	-12.90%	-8.27%	-5.04%	11.80%	-62.45%	-46.81%
Gross Profit	0.74	0.74	0.81	0.85	0.76	2.03
Selling, General & Admin	2.96	2.96	3.14	3.85	2.95	3.06
Research & Development	5.98	5.98	7.76	9.85	11.95	10.98
Operating Expenses	8.94	8.94	10.91	13.7	14.9	14.04
Operating Income	-8.2	-8.2	-10.1	-12.84	-14.14	-12.01
Other Expense / Income	-0.56	-0.56	0.08	-0.23	0.3	0.62
Pretax Income	-7.63	-7.63	-10.17	-12.62	-14.44	-12.63
Net Income	-7.63	-7.63	-10.17	-12.62	-14.44	-12.63
Preferred Dividends	0	0	0	2.59	0.72	0
Shares Outstanding (Basic)	1,278	1,278	816	553	358	86
Shares Outstanding (Diluted)	1,278	1,278	816	553	358	86
Shares Change	131.13%	56.71%	47.49%	54.31%	317.19%	120.84%
EPS (Basic)	-3.00	-3.00	-3.00	-9.00	-12.00	-42.00
EPS (Diluted)	-3.00	-3.00	-3.00	-9.00	-12.00	-42.00
Free Cash Flow	-8.44	-8.44	-10.81	-9.87	-12.09	-11.09
Free Cash Flow Per Share	-1.98	-1.98	-3.98	-5.35	-10.12	-38.72
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	-1102.96%	-1102.96%	-1246.42%	-1505.51%	-1853.08%	-590.90%
Profit Margin	-1027.46%	-1027.46%	-1255.93%	-1478.90%	-1892.92%	-621.31%
Free Cash Flow Margin	-1136.20%	-1136.20%	-1334.57%	-1156.98%	-1584.40%	-545.62%
EBITDA	-7.53	-7.53	-10.11	-12.55	-14.42	-12.61
EBITDA Margin	-1012.79%	-1012.79%	-1247.53%	-1470.81%	-1890.17%	-620.62%
Depreciation & Amortization	0.11	0.11	0.07	0.07	0.02	0.01
EBIT	-7.63	-7.63	-10.17	-12.62	-14.44	-12.63
EBIT Margin	-1027.46%	-1027.46%	-1255.93%	-1478.90%	-1892.92%	-621.31%

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).